hth官方网页版中国有限公司hth官方网页版中国有限公司

0571-87968248 ENGLISH
  • 首页
  • 关于我们
    公司介绍企业文化发展历程
  • hth官方网页版中国有限公司
    企业动态展会信息行业动态
  • 产品介绍
    新型冠状病毒(2019-nCoV)检测系列过敏原特异性抗体IgE检测系列食物特异性抗体IgG/lgG4检测系列单项/多价过敏原检测系列单组分过敏原检测系列过敏性疾病相关基因分子检测(PCR/NGS)系列产品其他系列产品产品专属设备--高通量全自动免疫印迹仪及判读软件
  • 过敏知识
    科研文献科普知识视频展示
  • 联系方式
    联系我们
科研文献科普知识视频展示
组分文献基因文献机理文献益生菌检测文献脱敏文献其他

JACI: 泪液骨膜蛋白测定对眼部变态反应性疾病的诊断和治疗价值

发布日期:2019-09-23

  原标题:泪液骨膜蛋白测定对眼部变态反应性疾病的诊断和治疗价值
——浙大迪迅 译
  ①背景:春季角膜结膜炎(VKC)、特应性角膜结膜炎(AKC)等慢性眼部变应性疾病均伴有严重的共病;然而,其潜在的发病机制仍不清楚。此外,对特应性皮炎患者结膜病变的诊断和AKC严重程度的估计对眼部变态反应性疾病的治疗具有重要意义。②目的:探讨骨膜蛋白作为一种新型的过敏性炎症介质和生物标志物,是否参与眼部过敏性疾病的发病过程,骨膜蛋白能否作为这些疾病的生物标志物。③方法:对季节性变应性结膜炎(SAC)、VKC、AKC患者及无结膜炎的过敏性疾病患者泪液骨膜蛋白进行研究,并与泪液IL-13、血清骨膜蛋白进行比较。此外,在AKC患者中,我们检测了外用他克莫司治疗前后的泪液骨膜蛋白。④结果:眼源性变应性疾病患者的泪液中骨膜蛋白含量明显高于无结膜炎的变应性疾病患者,AKC、VKC、SAC患者的泪液中骨膜蛋白含量依次下降。泪液骨膜蛋白与AKC中严重的乳头形成和角膜损伤等并发症有关,但泪液IL-13和血清骨膜蛋白几乎没有这种能力。此外,局部他克莫司治疗后,随着AKC患者临床症状的改善,大部分患者的泪液骨膜蛋白呈下降趋势。⑤结论:IL-13刺激结膜组织产生的骨膜蛋白可能是眼部变态反应性疾病的发病机制之一。此外,泪液骨膜蛋白可作为一种生物标志物,用于诊断变应性结膜炎的患者和评估疾病的严重程度以及AKC治疗的疗效。(J Allergy Clin Immunol 2016;nnn:nnn-nnn.)
延伸阅读
JACI
[IF:13.1]
The usefulness  of  measuring  tear  periostin  for the diagnosis and management of ocular allergic diseases
Dio.org/10.1016/j.jaci.2015.11.039
Abstract:
Background: Chronic ocular allergic diseases such as vernal kerato conjunctivitis (VKC) and atopic kerato conjunctivitis (AKC) are accompanied by serious comorbidities; however, the underlying pathogenesis remains obscure. Furthermore, diagnosing conjunctival lesions in patients with atopic dermatitis and estimating the severity in AKC are important for the treatment of ocular allergic diseases.
Objective: We addressed whether periostin, a novel mediator and biomarker in allergic inflammation, is involved in the pathogenesis of ocular allergic diseases and whether periostin can be a biomarker for these diseases.
Methods: We investigated tear periostin in patients with seasonal allergic conjunctivitis (SAC), VKC, and AKC and allergic patients without conjunctivitis and compared it with tear IL-13 and serum periostin. Furthermore, in patients with AKC, we measured tear periostin before and after topical treatment with tacrolimus.
Results: Tears from patients with ocular allergic disease showed significantly high periostin levels than did tears from allergic patients without conjunctivitis and from patients with AKC, VKC, and SAC in descending order. Tear  periostin was associated with serious comorbidities such as large papilla formation and corneal damage in AKC, although both tear IL-13 and serum periostin had little to no such abilities. Furthermore, after topical tacrolimus treatment, tear periostin tended to decrease in most patients with AKC along with their clinical improvement.
Conclusions: Periostin produced in conjunctival tissues stimulated by IL-13 may contribute to the pathogenesis of ocular allergic diseases. Furthermore, tear periostin can be potentially applied as a biomarker to diagnose conjunctivitis in allergic patients and to evaluate disease severity as well as the efficacy of treatments in AKC. (J Allergy Clin Immunol 2016;nnn:nnn-nnn.)
All Author:
Hiroshi Fujishima, MD,a* Naoko Okada, PhD,b* Kenji Matsumoto, MD, PhD,b Kazumi Fukagawa, MD, PhD,c,d Ayako Igarashi, BS,e Akio Matsuda, PhD,b Junya Ono, BS,f Shoichiro Ohta, MD, PhD,g Hideki Mukai, MD, PhD,h
Mamoru Yoshikawa, MD, PhD,i and Kenji Izuhara, MD, PhD
2019-8-30  Article 
  创建过敏性疾病的科研、科普知识交流平台,为过敏患者提供专业诊断、治疗、预防的共享平台。

  • 首页
  • 关于我们
  • hth官方网页版中国有限公司
  • 产品介绍
  • 过敏知识
  • 联系方式
hth官方网页版中国有限公司   版权所有    开创网络   技术支持    浙ICP备14005341号  
互联网药品信息服务资格证书编号: (浙)-非经营性-2019-0050
地址:杭州市滨江区滨康路568号2号楼     电话:0571-87968248-805      网址:www.szzyfzls.com
COPYRIGHT©2003-2024 www.szzyfzls.com CORPORATION. ALL RIGHTS RESERVED

浙大迪迅
官方微信

浙公网安备 33010802011114号

乐动网页版 | 江南游戏 | 开云在线登录 | 江南游戏 | 开云电子(中国)有限公司官网 | 乐竞网页版登录入口 | 九州平台 | 冠盈体育(中国)科技有限公司官网 | 乐动手机网页版登录入口 |